The abstract is read at the publisher; the summary is JClub's.
SOX4 restrains vascular smooth muscle cell osteogenic differentiation and aortic calcification, with SOX4 loss aggravating and SOX4 overexpression attenuating calcification in VitD3 and phosphate models.
- Why it matters: Vascular calcification is driven by VSMC osteogenic differentiation, but endogenous brakes that prevent this fate switch are not well defined.
- What they did: The study profiled SOX4 in calcified human arteries, VitD3-treated mouse aortas, and phosphate-treated human aortic smooth muscle cells, then used loss/gain of function, an HMG-box-deleted SOX4 mutant, and mechanistic assays (including RNA immunoprecipitation-seq and mRNA decay) plus VSMC-specific Sox4 knockout mice and WNT5A inhibition with BOX5.
- The result: SOX4 acted independently of DNA binding, interacted with HNRNPC to reduce HNRNPC-USP10 association, promoted K48-linked ubiquitination and proteasomal degradation of HNRNPC, lowered WNT5A expression, and BOX5 attenuated osteogenic differentiation in vitro and calcification in vivo in both genotypes.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.